Failure of therapeutic trials for Chronic Obstructive Lung Disease (COPD) reflects our poor mechanistic understanding of the disease. The long term goal of this project is to improve the mechanistic understanding of COPD. The two major pathologic features of COPD that contribute to airway obstruction are loss of alveolar walls and wall thickening of small airways (<2mm). Small airway changes progress with increasing severity of COPD and therefore represent a therapeutic target to stabilize or potentially reverse airway obstruction. Recent investigation suggests that TGF? is likely to play a major mechanistic role in wall thickening in COPD by regulating the balanced autocrine and paracrine interactions between airway epithelial and mesenchymal cell types, collectively known as the epithelial-mesenchymal trophic unit (EMTU). These autocrine and paracrine interactions dictate cellular differentiation during lung development. Imbalances in these interactions could result from chronic airway injury (e.g. tobacco smoke) and lead to airway remodeling. TGF? isoforms are expressed by all cell types within the EMTU, but almost entirely in an inactive form. Hence, activation of TGF? is a major point of regulation of TGF? function. We have recently developed one of the first in vitro models of the human EMTU (Araya, et al, Am. J. Path, 2006) and have used it to determine that the integrin av?8 plays a major role in TGF? activation, and subsequent autocrine and paracrine interactions between airway epithelial cells and fibroblasts. Using human COPD samples, we demonstrate increased ?8 expression in both the airway epithelium and small airway fibroblasts, which significantly correlates with declining pulmonary function and airway wall thickening. These findings have led us to our overall hypothesis: Increased av?8-dependent activation of TGF? in COPD airway epithelial cells and fibroblasts leads to inappropriate reactivation of morphogenic programs within the EMTU, which leads to airway remodeling. Using physiologically relevant primary human airway epithelial and fibroblast cell culture systems, we will: 1) determine the mechanism of increased (38 expression in COPD by airway epithelial cells and fibroblasts;2) determine mechanism of increased av?8-mediated activation of TGF? in COPD;3) determine the functional consequence of increased av?8-mediated activation of TGF? in autocrine and paracrine interactions between airway epithelial and fibroblast cell types. TGF? is one of the most fibrogenic cytokines known, but because of its normal homeostatic role in virtually all tissues, therapies targeted at global TGF? neutralization will also have undesired systemic effects. The TGF? activating integrin, av?8, is upregulated in COPD but has a highly restricted pattern of expression in normal human tissues making it a possible therapeutic target to specifically inhibit TGF? in COPD. This proposal is the first step in testing the therapeutic potential of inhibiting av?8 function in COPD.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL063993-10
Application #
8049210
Study Section
Lung Cellular, Molecular, and Immunobiology Study Section (LCMI)
Program Officer
Punturieri, Antonello
Project Start
1999-12-01
Project End
2013-03-31
Budget Start
2011-04-01
Budget End
2013-03-31
Support Year
10
Fiscal Year
2011
Total Cost
$347,625
Indirect Cost
Name
University of California San Francisco
Department
Pathology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Hashimoto, Mitsuo; Yanagisawa, Haruhiko; Minagawa, Shunsuke et al. (2015) A critical role for dendritic cells in the evolution of IL-1?-mediated murine airway disease. J Immunol 194:3962-9
Hashimoto, Mitsuo; Yanagisawa, Haruhiko; Minagawa, Shunsuke et al. (2015) TGF-?-Dependent Dendritic Cell Chemokinesis in Murine Models of Airway Disease. J Immunol 195:1182-90
Brand, Oliver J; Somanath, Sangeeta; Moermans, Catherine et al. (2015) Transforming Growth Factor-? and Interleukin-1? Signaling Pathways Converge on the Chemokine CCL20 Promoter. J Biol Chem 290:14717-28
Minagawa, Shunsuke; Lou, Jianlong; Seed, Robert I et al. (2014) Selective targeting of TGF-? activation to treat fibroinflammatory airway disease. Sci Transl Med 6:241ra79
Lee, Ting-Hein; McKleroy, William; Khalifeh-Soltani, Amin et al. (2014) Functional genomic screen identifies novel mediators of collagen uptake. Mol Biol Cell 25:583-93
Kitamura, Hideya; Cambier, Stephanie; Somanath, Sangeeta et al. (2011) Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin ýývýý8-mediated activation of TGF-ýý. J Clin Invest 121:2863-75
Markovics, Jennifer A; Araya, Jun; Cambier, Stephanie et al. (2011) Interleukin-1beta induces increased transcriptional activation of the transforming growth factor-beta-activating integrin subunit beta8 through altering chromatin architecture. J Biol Chem 286:36864-74
Araya, Jun; Nishimura, Stephen L (2010) Fibrogenic reactions in lung disease. Annu Rev Pathol 5:77-98
Markovics, Jennifer A; Araya, Jun; Cambier, Stephanie et al. (2010) Transcription of the transforming growth factor beta activating integrin beta8 subunit is regulated by SP3, AP-1, and the p38 pathway. J Biol Chem 285:24695-706
Su, Hua; Kim, Helen; Pawlikowska, Ludmila et al. (2010) Reduced expression of integrin alphavbeta8 is associated with brain arteriovenous malformation pathogenesis. Am J Pathol 176:1018-27

Showing the most recent 10 out of 18 publications